4C Medical Spółka z Ograniczoną Odpowiedzialnością (KRS 0000713594, NIP 7010796843) is a Polish company, headquartered in Warszawa, Mazowieckie voivodeship. 4C MEDICAL operates in: Business and other management consultancy activities (PKD 70.22.Z). Industry: Consulting and management. The company has been listed in the National Court Register since January 12, 2018. 4C MEDICAL's operations are currently suspended.
The company is currently suspended
Suspended since August 1, 2025
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - 4C Medical
Identity
- Name
- 4C Medical Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- January 12, 2018
- Registry status as of
- November 21, 2025
- Latest entry
- July 28, 2025
- Founding act
- 03.01.2018
Articles of association history (2)
- January 3, 2018: 03.01.2018
- June 21, 2018: 21.06.2018 R., REP. A NR 1969/2018, NOTARIUSZ MAŁGORZATA SABINA ROSMANN, KANCELARIA NOTARIALNA W WARSZAWIE, ZMIANA: §2, §4, §9, §10, §11, §13, §14, §16
Activities
Main activity
70.22.ZBusiness and other management consultancy activities
Other activities
Address and contact
- Address
- UL. ZYGMUNTA GLOGERA, 2, 11, 02-051, WARSZAWA, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- WARSZAWA
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
- Coordinates
- 52.2298, 21.0117approx.
Operational status - 4C Medical
Founded
January 12, 2018
8 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WARSZAWA
MAZOWIECKIE
Primary PKD
70.22.Z
Business and other management consultancy activities
Share capital
10.0 K PLN
100 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
N/A
Registry entries
20
latest: July 28, 2025
Risk signals
No KPI data - financial statements and valuation are unavailable for this company.
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - 4C Medical.
No ratings
Related articles
News
MLP Group 2026: net profit PLN 459 m (+23% YoY), a record 370,941 sqm leased, EBIT PLN 702 m and the first dividend policy since 2019 announced for 2026
Pruszków-based MLP Group S.A. (KRS 0000053299) - a developer and operator of logistics-warehouse parks in Poland, Germany, Austria, Romania and the Netherlands - closed 2025 with net profit of PLN 459.0 m (+23.3% YoY vs PLN 372.2 m) and EBIT of PLN 701.7 m (+29.2%). Rental revenue PLN 238.4 m (+10%), property-management services PLN 182.1 m (+15.5%). 2025 leasing volume: a record 370,941 sqm (new + renewals). EPS PLN 19.13 (+23.3%), equity PLN 3,197 m (+16.4%), assets PLN 6.99 bn. After a seven-year break the company announces a dividend policy in 2026. 2026 target: +20–30% revenue growth, around 250–300 k sqm of new buildings, 60% of capex allocated to Germany.
News
Murapol 2026: PLN 4.90 per share dividend (yield ~11.9%) - the highest in the WSE developer sector, net profit PLN 236 m, gross margin 36.5% (+4 pp), 2,856 apartments sold
Bielsko-Biała Murapol S.A. (KRS 0000275523), a residential developer with property portfolio in 8+ Polish cities, posted 2025 net profit of PLN 236 m (-2.5% YoY), revenue PLN 1.26 bn (-5.2%) and gross sales margin of 36.5% (vs 32.4%, +4 pp). Operating cash flow jumped to PLN 311 m (vs PLN 100 m, ~3×). Net sales: 2,856 apartments (-2%), handed over 2,650 (-9%). In 2026 expected handovers ~3,000 units; Q1 2026 sales of 735 apartments (+4% YoY). Dividend for 2025 totals PLN 4.90 per share (December 2025 advance PLN 2.94 + second tranche PLN 1.97), yield ~11.9% - the highest in the WSE developer sector.
